Sun Yat-sen University clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 1,680 studies whose lead sponsor is Sun Yat-sen University. 609 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the Sun Yat-sen University studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStatus
Focus areas
Conditions Sun Yat-sen University leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Nasopharyngeal Carcinoma207Carcinoma, Hepatocellular175Carcinoma, Non-Small-Cell Lung98Colorectal Neoplasms91Lung Neoplasms85Lymphoma58Cataract57Breast Neoplasms56Neoplasm Metastasis44Nasopharyngeal Neoplasms38Rectal Neoplasms36Esophageal Squamous Cell Carcinoma32Stomach Neoplasms28Neoplasms26Carcinoma, Squamous Cell25Lymphoma, T-Cell, Peripheral24Esophageal Neoplasms23Eye Diseases23Brain Neoplasms21Diabetes Mellitus21Diabetes Mellitus, Type 221Glaucoma21Myopia21Lymphoma, Large B-Cell, Diffuse19
Show all 44 areas
Hepatitis B18Liver Neoplasms16Sarcoma16Squamous Cell Carcinoma of Head and Neck16Uterine Cervical Neoplasms15Graves Ophthalmopathy14Kidney Diseases13Prostatic Neoplasms13Carcinoma, Renal Cell12Small Cell Lung Carcinoma12Adenocarcinoma11Colonic Neoplasms11Liver Diseases11Lymphoma, B-Cell11Retinal Diseases11Diabetic Retinopathy10Lymphoma, Extranodal NK-T-Cell10Lymphoma, Non-Hodgkin10Spondylarthritis10Triple Negative Breast Neoplasms10
Studies
Recruiting first, then most recently updated. Showing 50 of 1,680. Browse all 1,680 →
- Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular CarcinomaRecruitingNCT06644430
- An Exploratory Study on the Failure of Immunotherapy With Vorolanib Combined With EverolimusRecruitingNCT06730672Phase 2
- Remimazolam vs Propofol for Long-Term Sedation in Mechanically Ventilated ICU PatientsNot yet recruitingNCT07880548Phase 3
- Becotatug Vedotin + Pucotenlimab+Platinum Induction and Sequential CCRT for Unresectable LA NSCLCNot yet recruitingNCT07882940Phase 2
- FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)Not yet recruitingNCT07621497Phase 2
- Phase II Trial of Hypofractionated Radiotherapy Guided by Optical Surface Imaging and Fan-beam CT for Thymoma With Pleural MetastasisNot yet recruitingNCT07879417Phase 2
- Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal CancerRecruitingNCT07448142Phase 2
- Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chemoradiotherapy-Related Anorexia in Nasopharyngeal CarcinomaRecruitingNCT07796789Phase 3
- HR20013 for the Prevention of Nausea and Vomiting in Patients With Cancer: A Real-World StudyRecruitingNCT07874308
- Prospective Phase II Study of Concurrent Radiotherapy Combined With Full-Course Immunotherapy or Consolidation Immunotherapy for Locally Advanced NSCLCNot yet recruitingNCT07874464Phase 2
- Lenvatinib Plus Bevacizumab and PD-1 Inhibition Versus Bevacizumab Plus PD-1 Inhibition After Progression on Bevacizumab Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Prospective, Randomized, Two-Cohort, Phase II StudyNot yet recruitingNCT07870772Phase 2
- A Phase II Study of Anlotinib + PD-1 Inhibitor vs. PD-1 Inhibitor Maintenance After First-Line Chemoimmunotherapy in Advanced ESCC (Esophageal Squamous Cell Carcinoma)RecruitingNCT07863141Phase 2
- Cryoablation Combined With Hepatic Arterial Infusion of Iparomlimab and Tuvonralimab (QL1706), Intravenous Dacarbazine, and Oral Lenvatinib in Patients With Liver Metastases From Malignant Melanoma: a Single-arm, Phase II, Prospective TrialRecruitingNCT07847359Phase 2
- HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular CarcinomaRecruitingNCT06737913Phase 2
- Multi-Theory Model-Based AI Agent Intervention for Smoking Cessation in Early-Stage Cancer PatientsNot yet recruitingNCT07827066Not applicable
- Neoadjuvant Radiotherapy Combined With NALIRIFOX and Adebrelimab in pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Randomized, Phase II Clinical TrialRecruitingNCT07622771Phase 2
- Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal CarcinomaNot yet recruitingNCT07824856Phase 2
- High Quality Evidence of Chinese Lupus Nephritis (HELP)RecruitingNCT03001973
- Super Chinese Nephrotic Syndrome Registration System (SUCCESS)RecruitingNCT03001934
- Wise Practice of Chinese Hemodialysis (WISHES)RecruitingNCT03001921
- IgA Nephropathy Registration Initiative of High Quality (INSIGHT)RecruitingNCT03001947
- Peritoneal Dialysis Registration System (PERSIST)RecruitingNCT02989298
- Ivosidenib Plus mFOLFOXIRI and Celecoxib for BRAF-targeted Therapy-refractory BRAF V600E-mutant Colorectal Cancer PatientsRecruitingNCT07809893Phase 2
- TEER In dynaMic sEvere Functional Mitral Regurgitation (TIMER)Not yet recruitingNCT07197021Not applicable
- SBRT Versus Surgical Resection for Small HCCRecruitingNCT07381660Phase 3
- Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate CancerRecruitingNCT06854250Phase 2
- PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPCRecruitingNCT07235319Phase 3
- Effects of Different PICC Catheterization Methods: A Multicenter Randomized Controlled TrialNot yet recruitingNCT07791719Not applicable
- VIPeerAgent for Adolescent Mental HealthNot yet recruitingNCT07778758Not applicable
- Trastuzumab Rezetecan and Carboplatin ± Bevacizumab Versus Investigator's Choice Chemotherapy in Patients With Platinum-sensitive Recurrent Ovarian CancerNot yet recruitingNCT07776171Phase 2
- Research on Colorectal Cancer Recurrence Monitoring and Individualized Treatment Based on MRDRecruitingNCT07775950Not applicable
- Individualized Primary Clinical Target Volume Based on Margin Expansion for Nasopharyngeal CarcinomaRecruitingNCT07661771Phase 3
- Radiotherapy Combined With Capeox Chemotherapy, Sintilimab and Suvemcitug in Locally Advanced pMMR Rectal Cancer:a Prospective Clinical TrialNot yet recruitingNCT07774754Phase 2
- Neoadjuvant Presurgical Becotatug Vedotin (MRG003) Plus Pucotenlimab (HX008) in Oral Cavity Squamous Cell CarcinomaNot yet recruitingNCT07766889Phase 2
- Neoadjuvant Pucotenlimab and Becotatug Vedotin for Locally Advanced Penile CancerNot yet recruitingNCT07767266Phase 2
- Megestrol Acetate for Fatigue Management in T-DXd Treated Breast CancerRecruitingNCT07543536Phase 3
- Tunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant MelanomaRecruitingNCT07750067Phase 2
- Radscopal Radiotherapy Plus Immunotherapy for Chemotherapy-Ineligible Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer: A Single-Center, Open-Label, Phase II StudyNot yet recruitingNCT07756190Phase 2
- Golidocitinib Plus Anthracycline-based Therapy for Untreated Nodal T-follicular Helper (TFH) Cell LymphomaNot yet recruitingNCT07753642Phase 2
- Neoadjuvant Chemoradiotherapy Combined With CTLA-4 Monoclonal Antibody Plus PD-1 Monoclonal Antibody for Locally Advanced Esophageal CancerRecruitingNCT07751055Phase 2
- Culmerciclib Plus Anlotinib and Endocrine Therapy for HR-Positive/HER2-Negative Metastatic Breast Cancer With Brain MetastasesNot yet recruitingNCT07745257Phase 2
- Culmerciclib in HR+/HER2+ Advanced Breast CancerRecruitingNCT07732491Phase 2
- FOLFIRI Plus Bevacizuamb and QL1706 in Second-Line Treatment for mCRCNot yet recruitingNCT07729605Phase 3
- Dapagliflozin Add-on in Unresectable HCC With Metabolic SyndromeNot yet recruitingNCT07729592Phase 2
- Maintenance Immunotherapy With Deferred Salvage Radiotherapy After Response to Chemoimmunotherapy in Recurrent Nasopharyngeal CarcinomaRecruitingNCT07528183Phase 2
- Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCLRecruitingNCT07494565Phase 2
- Efficacy and Safety of Tunlametinib Combination Therapy in the Treatment of Second-line and Above Metastatic Colorectal CancerNot yet recruitingNCT07714447Phase 2
- Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT07064902Phase 2
- An Umbrella-designed Prospective Multicenter Randomized Open-label Superiority Trial Evaluating Multi-biomarker-guided Precision Therapy for First-line Treatment of Advanced Esophageal Squamous Cell CarcinomaNot yet recruitingNCT07709533Phase 2
- Efficacy and Safety of TPC Induction Chemotherapy Combined With Nimotuzumab and Toripalimab "Immune Sandwich" Regimen Versus Full-Course Immunotherapy for Locally Advanced Nasopharyngeal CarcinomaRecruitingNCT07706985Phase 3